(Q45053412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

retracted paper

3 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

PubMed

https://github.com/jmillanacosta/retractable/blob/e28dcac33244e89948fe17fb65f09b59e2ed804d/data/PMIDS_DOIS.csv

title

Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Agustin Avilés

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Raúl Fernándezb

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Felipe Pérez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M Jesús Nambo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Alejandra Talavera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Claudia Castañeda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Martha González

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sergio Cleto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1385-1389

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

The integration of radiotherapy into the primary treatment of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Dose escalation of epirubicin in the CEOP-BLEO regimen: a controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001667712

10.1080/10428190410001667712

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15359637%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference